Environmental risk factors for prevention and molecular intervention of cervical cancer

被引:18
作者
Au, William W. [1 ]
Abdou-Salama, Salama [2 ]
Sierra-Torres, Carlos H. [3 ]
Al-Hendy, Ayman [2 ]
机构
[1] Univ Texas Galveston, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA
[2] Univ Texas Galveston, Med Branch, Dept Obstet & Gynecol, Galveston, TX 77550 USA
[3] Univ Cauca, Fac Ciencies Salud, Dept Ciencias Fisiol, Lab Genet Humana, Popayan, Colombia
关键词
cervical cancer; HPV infection; cigarette smoking; SiRNA; estrogen; cancer prevention; dominant negative estrogen receptor; molecular therapy; gene therapy;
D O I
10.1016/j.ijheh.2006.10.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cervical cancer (CC) is potentially the most preventable and treatable cancer in human but it is a leading cause for cancer morbidity and mortality in women around the world. Therefore, more innovative prevention and treatment protocols need to be developed and implemented. With better understanding of the etiology of the disease, specific prevention protocols that involve life-style modifications to minimize the impact of environmental risk factors can be developed. It may be necessary to implement unique modification protocols for different countries. In addition, antiviral vaccine is a highly promising prevention approach. With respect to therapy, the development of more specific protocols that have fewer side effects is needed. With the availability of sophisticated molecular techniques, a new generation of targeted approach that has the potential to generate outstanding efficacy is being tested. Using the siRNA technology against the expression of human papillomavirus oncogenes, specific biological pathways that are essential to the growth and survival of the CC cells can be interrupted. Another promising approach is the molecular intervention of the estrogen pathway by blocking the expression of estrogen receptors. These molecular techniques may work by reactivating endogenous regulatory processes, e.g., the core apoptotic machinery, that can cause self-destruction of the CC cells, thus providing potentially effective molecular therapy. These topics are discussed in this review. (c) 2006 Elsevier GmbH. All rights reserved.
引用
收藏
页码:671 / 678
页数:8
相关论文
共 65 条
[1]   Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells [J].
Al Moustafa, AE ;
Foulkes, WD ;
Wong, A ;
Jallal, H ;
Batist, G ;
Yu, QY ;
Herlyn, M ;
Sicinski, P ;
Alaoui-Jamali, MA .
ONCOGENE, 2004, 23 (30) :5252-5256
[2]   Gene therapy of uterine leiomyomas: Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice [J].
Al-Hendy, A ;
Lee, EJ ;
Wang, HQ ;
Copland, JA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (05) :1621-1631
[3]   Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: Biologic function and clinical significance [J].
Almadori, G ;
Galli, J ;
Cadoni, G ;
Bussu, F ;
Maurizi, M .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (06) :597-604
[4]   Life style, environmental and genetic susceptibility to cervical cancer [J].
Au, WW .
TOXICOLOGY, 2004, 198 (1-3) :117-120
[5]   Acquired and genetic susceptibility to cervical cancer [J].
Au, WW ;
Sierra-Torres, CH ;
Tyring, SK .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003, 544 (2-3) :361-364
[6]  
AU WW, 2006, IN PRESS GYNECOL ONC
[7]  
AU WW, 2005, MUTAT RES, V577, P491
[8]   The epidemiology of human papillomavirus infections [J].
Baseman, JG ;
Koutsky, LA .
JOURNAL OF CLINICAL VIROLOGY, 2005, 32 :S16-S24
[9]   Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model [J].
Brake, T ;
Lambert, PF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2490-2495
[10]  
Brewer Joyce, 2005, V41, P68